Becton Dickinson and Company (BDX)

256.46
+3.96(+1.57%)
After Hours
256.46
0.00(0.00%)
- Real-time Data
  • Volume:
    697,259
  • Day's Range:
    252.54 - 256.46
  • 52 wk Range:
    235.13 - 280.62

BDX Overview

Prev. Close
252.5
Day's Range
252.54-256.46
Revenue
20.03B
Open
254.04
52 wk Range
235.13-280.62
EPS
6.34
Volume
697,259
Market Cap
73.11B
Dividend (Yield)
3.48
(1.36%)
Average Vol. (3m)
1,203,913
P/E Ratio
40.44
Beta
0.64
1-Year Change
6.44%
Shares Outstanding
285,064,629
Next Earnings Date
Aug 04, 2022
What is your sentiment on Becton Dickinson?
or
Market is currently closed. Voting is open during market hours.

Becton Dickinson and Company News

Becton Dickinson and Company Analysis

Becton Dickinson and Company Company Profile

Becton Dickinson and Company Company Profile

Becton, Dickinson and Company (BD) is a global medical technology company engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products. The Company operates through three business segments: BD Medical, BD Life Sciences and BD Interventional. The BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings. BD Medical consists of various business units, including medication delivery solutions, medication management solutions, diabetes care and pharmaceutical systems. The BD Life Sciences segment provides products for the safe collection and transport of diagnostics specimens, and instruments and reagent systems to detect a range of infectious diseases, healthcare-associated infections and cancers. The BD Interventional segment provides vascular, urology, oncology and surgical specialty products.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyStrong BuyStrong BuyBuyBuy
Technical IndicatorsStrong BuyStrong BuyStrong BuyStrong BuyBuy
SummaryStrong BuyStrong BuyStrong BuyStrong BuyBuy
  • Can someone tell me the difference between this stock and AMBU(danish company). Becides the fact that AMBU is valued 1/5 of BDX…
    0
    • anyone an idea for a target?
      0
      • $240
        0
    • https://www.fool.com/investing/2021/02/27/these-3-stocks-big-winners-from-president-biden/?source=eptyholnk0000202&utm_source=yahoo-host&utm_medium=feed&utm_campaign=article
      0
      • Last chance to get in , DPA will give a big boost in a few weeks.
        1
        • Rajeesh Raju good luck
          0
        • Lode Schepershttps://www.nasdaq.com/articles/becton-dickinson-gets-eua-for-new-diagnostic-test-2021-02-14
          0
        • Rajeesh Raju Thank you very much. Succes!
          0
      • bye bye b d x you stepped on Elon Musk toes
        2
        • what happened ?
          0
      • https://www.biospace.com/article/releases/cardiff-oncology-prices-public-offering-sep-30-2020/
        0
        • 300$ by end of 2020
          1
          • We need to see at least 230 before its worth getting into.
            2
            • insane earnings, insane share price, insane P/E ratio
              0
              • P/E isn't insane, 91 is without NRI, forward P/E is 20. At 15 it would be a good entry point but the price would have to be $180.
                0
            • . I want to know if this asset comes in at 192 this week? What do you guys think?
              0
              • I would pull the trigger at $180 with a forward P/E of 15.
                0